Acid Reducer Major

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acid Reducer Major

Quick Facts: Acid Reducer Major

Property Description
Active ingredient Cimetidine
Forms Tablet, Oral Solution, Injection
Pharmacological class Histamine H₂-receptor antagonist (H₂-blocker)
Common use Reduction of stomach acid production
Origin Synthetic compound

What Type of Medicine is Acid Reducer Major?

Acid Reducer Major is a synthetic compound medicine whose active ingredient is Cimetidine, classifying it as a Histamine H₂-receptor antagonist or H₂-blocker. This classification positions the drug as an antisecretory agent, meaning it works systemically to inhibit the production of acid. The medicine is clinically recognized for its specific action of blocking the histamine H₂ receptors found on the parietal cells in the stomach lining, which prevents the chemical signal that triggers acid secretion. Cimetidine was historically one of the first major compounds in this H₂-blocker class and has a long history of use in gastric acid control.


Composition and General Purpose

The composition centers on the active ingredient Cimetidine, formulated alongside necessary inert excipients to create various pharmaceutical preparations. These preparations commonly include the tablet form for standard oral use, as well as an oral solution and solutions designed for parenteral administration. The general purpose of using Acid Reducer Major is to achieve significant and sustained reduction of stomach acid production by interfering with the acid-releasing mechanism. This systemic effect fulfills the objective of creating a protective, lower-acidity environment in the upper gastrointestinal tract, which is the foundational benefit for individuals experiencing high gastric acidity.

Regulatory References

  1. Cimetidine - StatPearls - NCBI Bookshelf
  2. Cimetidine: MedlinePlus Drug Information

What side effects are possible with Acid Reducer Major?

Possible Side Effects and Safety Information

The official safety profile for Acid Reducer Major (Cimetidine) classifies adverse reactions based on frequency and the physiological system affected, adhering to regulatory standards. The safety information addresses both common occurrences and rare, serious events documented in clinical use.


Frequency and System Classification

Adverse reactions are formally categorized in regulatory documentation. Common effects typically include headache, dizziness, tiredness, and gastrointestinal disturbances such as diarrhea and nausea. Effects are grouped by the affected System-Organ Class, which includes Nervous System Disorders, Gastrointestinal Disorders, and Hepatobiliary Disorders.

Uncommon effects include confusion, agitation, myalgia (muscle pain), and arthralgia (joint pain). The potential for reversible CNS effects like confusion is noted to be more common at high doses or in patients with underlying renal impairment.


Serious Adverse Reactions and Special Considerations

Regulatory sources explicitly document the potential for Rare but serious adverse reactions, including specific hematological disorders (e.g., agranulocytosis, thrombocytopenia), hepatitis, and cardiac effects such as arrhythmias and bradycardia.

Population-specific safety notes highlight that older adults are at an increased risk of CNS adverse effects. For patients with renal impairment, a dosage adjustment is necessary due to reduced clearance, which heightens the risk of toxicity. Additionally, gynecomastia is documented as an effect associated with prolonged or long-term administration.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information details the manifestations and required immediate actions in the event of an overdose of Acid Reducer Major (Cimetidine). While acute oral overdosage of up to 20 grams has been reported with no significant ill effects, the potential for severe outcomes necessitates strict adherence to emergency guidance. Documented signs of high-dose exposure include drowsiness, confusion, slurred speech, and gastrointestinal upset.


Documented Severity and Emergency Action

Severity Indicator Associated Outcome / Action
Severe Outcomes Seizures, collapse, low blood pressure, abnormal heartbeat, or difficulty breathing may occur.
High-Risk Populations Elderly or patients with renal/hepatic impairment are susceptible to confusional states.
Immediate Action Contact a Poison Control Center immediately upon suspected overdose.

If the individual is experiencing severe symptoms such as a seizure, collapse, or trouble breathing, emergency services (911) must be called immediately. Management focuses on symptomatic and supportive therapy, as no specific antidote is known. Hospital monitoring, including ECG and vital signs checks, is typically required.

Therapeutic Uses of Acid Reducer Major

What Acid Reducer Major Treats: Main Uses and Benefits

Acid Reducer Major (Cimetidine) is commonly used to provide symptomatic relief and therapeutic support across key areas of upper gastrointestinal distress caused by excessive stomach acid, and may help patients cope more steadily with symptom fluctuations. The medication is considered relevant for addressing conditions where symptoms are driven by heightened physiological activity in the stomach.

The medicine is relevant for easing symptoms and providing support in conditions such as active gastric and duodenal ulcers, Gastroesophageal Reflux Disease (GERD), erosive esophagitis, and pathological hypersecretory states like Zollinger-Ellison syndrome. Applied across domains where additional symptomatic support is needed, it helps address symptom clusters related to intense epigastric pain, persistent heartburn, and acid regurgitation.

“The primary goal of using this medication is to help ease the overall symptom burden by addressing the irritation caused by excessive acid, and contributes to improved comfort during periods of heightened symptoms.”

Easing Pain and Supporting Ulceration Management

This medication is commonly used across conditions characterized by episodic or fluctuating manifestations related to Peptic Ulcer Disease (PUD). It is applied to address intense epigastric pain and associated discomfort from active ulcers, providing support that helps ease the overall symptom burden and provides supportive relief when symptoms interfere with routine activities during treatment.


Quick Fact: Relief for Acid-Related Discomfort
Symptom Clusters Helps address symptoms related to physical discomfort like pain and heartburn
Relevant Contexts Used in situations involving certain distressing symptoms
Primary Benefit Contributes to improved day-to-day comfort during symptomatic periods

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for using Acid Reducer Major (Cimetidine) is defined by regulatory documents based on patient population, age, and pre-existing conditions.

Contraindicated and Restricted Populations

Classification Population Group Condition for Use
Contraindicated Patients with known hypersensitivity to Cimetidine Must not use the medicine.
Patients concurrently taking dofetilide Use is prohibited due to a severe interaction risk.
Conditional Use Patients with impaired renal function Requires dosage reduction as specified in official labeling.
Patients with severe hepatic impairment Use requires caution and may necessitate dosage adjustment.

Age-Related Eligibility

The medicine is generally approved for adults and adolescents ge 12 years of age. Use in children ge 2 years of age is allowed under defined protocols, though regulatory experience is less extensive than in adults. Use in children under two years old is officially categorized as not fully established by some regulators. Older adults are eligible but should be monitored, as impaired kidney function in this group increases the risk of certain central nervous system effects.

Pregnancy and Lactation

Use during pregnancy is permitted only if it is clearly needed and the benefit outweighs potential risk (US FDA Pregnancy Category B). Cimetidine is not recommended for use by breastfeeding women, as the drug is known to be excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acid Reducer Major can significantly interact with other medications by altering the pH (acidity) of the stomach. This change in gastric pH is the primary mechanism that affects how certain co-administered drugs are absorbed into the body, leading to clinically important drug-drug interactions.

Mechanism Basis Affected Drug Categories Potential Result
Increased Gastric pH Weak-Base Drugs (e.g., certain antivirals, antifungals, oncology agents) Decreased Absorption/Bioavailability and potential loss of drug efficacy.
Increased Gastric pH Weak-Acid Drugs Increased Absorption/Bioavailability and potential for increased side effects.

Specific interacting medicines and classes include certain antiretroviral drugs (such as atazanavir), and drugs that are highly dependent on an acidic stomach environment for proper dissolution and absorption. Due to the prolonged effect of this type of acid reducer, timing and dosage restrictions are essential to manage these interactions.

For example, if certain HIV treatments are co-administered, regulatory agencies may specify a maximum dose for the acid reducer or require separating the administration of the two medications by a significant time interval (e.g., at least 12 hours). Some combinations are contraindicated (should not be used together) in certain patient populations to avoid treatment failure. Consult with a healthcare professional before combining any acid reducer with prescription medications.

Mechanism of Action

Molecular Mechanism: Histamine H2 Receptor Antagonism

Acid Reducer Major (Cimetidine) exerts its effect by initiating a competitive blockade at the Histamine H2 receptors found on the basolateral surface of the gastric parietal cells. By occupying these receptor sites, the molecule prevents the natural chemical signal, histamine, from binding and activating the cell. This specific interaction is central to the drug's antisecretory properties.

Intracellular Signaling Disruption

Blocking the receptor halts the subsequent activation of the adenylate cyclase enzyme, resulting in a decrease in the intracellular signaling molecule, cyclic adenosine monophosphate (cAMP). This early molecular step diminishes the downstream signaling necessary for the full activation and translocation of the H^+/ K^+-ATPase (Proton Pump) to the cell membrane.

⬆️ Resulting Physiological Modulation

The systemic consequence of this targeted cellular mechanism is a profound inhibition of gastric acid output. This action applies to both continuous basal secretion and the increased production stimulated by physiological events. The direct physiological outcome is an elevation of the intragastric pH, achieved by limiting the release of hydrogen ions ( H^+) into the stomach lumen.

Dosage and Administration Information

How to Use Acid Reducer Major

Acid Reducer Major (Cimetidine) is administered via oral and parenteral routes, following established protocols concerning dose, frequency, and duration. Oral forms, including tablets and solution, are used for standard outpatient care, while solutions for injection (Intravenous or Intramuscular) are reserved for institutional settings, such as when oral intake is not feasible. The medicine may be taken with or without food, though taking it with a meal can prolong the acid-reducing effect.


Administration Patterns and Dosing Schedules

Administration frequency varies based on the condition being addressed. For active ulcers, high-level regimens often prescribe 800 mg once daily at bedtime, or a divided dose such as 400 mg twice daily. For maintenance therapy, a reduced dose, typically 400 mg, is taken once daily at bedtime. In cases of pathological hypersecretion, the dose is generally 300 mg four times daily, with doses scheduled around mealtimes and at bedtime, and the total daily dose should not exceed 2.4 g.


Procedural Requirements and Duration

For intravenous administration, the injection must be diluted and administered very slowly over a minimum of five minutes, or administered as an infusion. Patients with significantly impaired renal function require a dose reduction, with regimens adjusted to a lower total daily intake (e.g., 300 mg every 12 hours) to account for altered drug clearance. Treatment duration for active disease is typically 4 to 8 weeks, while maintenance therapy may be continued for extended periods to prevent recurrence.

Recent Clinical Evidence

The historical research base for Acid Reducer Major (Cimetidine) primarily consists of foundational short-term Randomized Controlled Trials (RCTs) and double-blind controlled studies. These studies focused on duodenal and benign gastric ulcers in adults, measuring outcomes like endoscopic healing rates of the ulcer crater and patient-reported discomfort over periods typically lasting 4 to 8 weeks. Research also explored the drug's use in long-term studies that monitored patients for a year or more to track recurrence rates as an outcome in studies of long-term management.

For Gastroesophageal Reflux Disease (GERD), studies, including systematic reviews and meta-analyses, examined outcomes related to physical discomfort. These included measurements of symptom change for heartburn and measurements of healing for erosive esophagitis over short courses (up to 12 weeks). Trials reported patterns of symptom change, though evidence quality varies and findings were mixed when comparing outcomes monitored in different patient groups.

Limitations in the evidence base must be considered. Much of the foundational data precedes modern treatment standards, particularly the widespread adoption of H. pylori eradication therapy. Consequently, comparative evidence is lacking in the context of recent, large-scale studies against newer acid-reducing medications. Furthermore, long-term effects are not fully established for continuous use, and data for certain groups, such such as pediatric populations or individuals with multiple existing conditions, remains insufficient.

Key Studies & References

  1. Label: CIMETIDINE tablet, film coated - DailyMed (FDA Monograph)

Frequently Asked Questions (FAQ)

Common questions about Acid Reducer Major (FAQ)

Q: How quickly does Acid Reducer Major start to work after the first dose?

A: The official product information indicates that the medicine starts to reduce stomach acid production relatively quickly. This effect usually begins within approximately 30 to 60 minutes after an oral dose is taken. This time frame represents when the drug has been absorbed enough to start its work.

Q: What is the main difference between Acid Reducer Major and a standard antacid?

A: This medicine, a type of H₂-blocker, works differently from standard antacids. Antacids act by neutralizing the acid that is already present in your stomach. In contrast, regulatory documents describe this drug as working systemically to block the signal that causes the stomach to produce new acid in the first place.

Q: Is it true that Acid Reducer Major can affect how the body absorbs certain vitamins or minerals?

A: Studies reviewed by official agencies indicate that prolonged use of this medication may lead to decreased absorption of Vitamin B12. This happens because the reduction in stomach acid can affect the natural release of B12 from food.

Q: Are there any specific foods or supplements that should be avoided while using this medication?

A: The official product label does not specifically instruct patients to avoid particular foods. However, official regulatory information notes that altering the acidity (pH) of the stomach may affect how certain supplements are absorbed by the body.

Q: Are there known interactions between Acid Reducer Major and over-the-counter cold or flu remedies?

A: Due to how this medicine works, it changes the acidity in the stomach. Official documents indicate this can alter how the body absorbs many other co-administered medications, including some in over-the-counter cold and flu remedies. The regulatory information includes a full interaction list to describe how the drug may alter the absorption of many co-administered medications.

Q: Is Acid Reducer Major a drug that can be stopped without needing to gradually reduce the dose?

A: Official patient information suggests that for short-term courses, the medication may be stopped once the treatment duration is complete. However, if the drug has been used continuously for a prolonged period, some patients may experience a temporary return of acid symptoms, sometimes called 'acid rebound.'

Q: Does Acid Reducer Major have a known effect on sleep quality or vivid dreams?

A: The drug's official safety profile lists central nervous system (CNS) effects, which involve the brain and nerves, as possible side effects. These can include dizziness and agitation, and may interfere with a patient's normal rest patterns.

Q: Can people with pre-existing heart conditions use Acid Reducer Major according to official information?

A: Regulatory documents note a rare risk of adverse effects on the cardiovascular system, which may include changes to heart rhythm (arrhythmias). Official guidance states that due to this risk, individuals with known heart conditions are conditional users of this drug.

Q: What are the general consequences if a dose of Acid Reducer Major is missed or taken late?

A: Official patient instructions provide guidance on how to manage a missed dose, typically advising users to skip the dose if it is almost time for the next scheduled intake. Full instructions on managing a missed dose are found in the patient information leaflet.

Q: What happens when Acid Reducer Major is taken with alcohol, based on official warnings?

A: Official warnings caution against the consumption of alcohol while using this medicine, noting that evidence suggests the medication may increase the concentration of alcohol absorbed into the bloodstream.

Q: Is it common to experience a temporary increase in headaches when first starting Acid Reducer Major?

A: Headache is classified in official regulatory documentation as a common adverse reaction. For many patients, these common effects, including headache, may be most noticeable in the early stages of treatment as the body adjusts to the medicine.

Q: Does Acid Reducer Major interact with common herbal remedies like St. John's Wort or Turmeric?

A: As described in regulatory documents, this medicine works by changing the acidity of the stomach. This mechanism can affect how the body absorbs various co-administered substances, including some herbal remedies and supplements.

Q: What is the reason that official sources often recommend taking Acid Reducer Major a certain amount of time before a meal?

A: The common recommendation to take the medicine before a meal is based on maximizing its effect. This timing allows the drug to be fully absorbed and ready to block the acid-producing cells before a meal triggers a large release of stomach acid.

Q: Can the tablet or capsule form of Acid Reducer Major be split, chewed, or crushed?

A: Official instructions for the tablet form often indicate that it may be split. However, since the medicine comes in various forms (tablets, capsules, solutions), for proper handling, regulatory guidance advises reviewing the specific patient information sheet for the exact form prescribed.

Q: Are there specific regulatory warnings about taking Acid Reducer Major with blood-thinning medications?

A: Regulatory warnings state that this medicine can interact significantly with certain blood-thinning drugs. This interaction can increase the concentration of the blood thinner in the body, which raises the potential risk of bleeding. If these medicines are used together, regulatory bodies indicate that close clinical monitoring is required due to the potential risk of bleeding.

Q: What are the signs of a severe or allergic reaction to Acid Reducer Major that are listed in official documents?

A: Official safety information explicitly lists that hypersensitivity reactions—which are severe reactions—can occur. Signs documented as related to these serious reactions include rash, fever, and difficulty breathing.

Q: What is the typical duration of acid suppression achieved by one full dose of this drug?

A: Regulatory drug profiles define the duration of acid suppression as the period during which the medicine actively maintains reduced acid levels. After a single dose, this period typically lasts for about 6 to 8 hours.

Q: What happens if Acid Reducer Major is left outside of its original bottle or blister pack?

A: Regulatory storage guidelines emphasize keeping the medicine in its original container, tightly closed. This protection is necessary to prevent the product from moisture and degradation, which could otherwise compromise its stability and potency over time.

Q: Is it common to have stomach upset, gas, or bloating when first adjusting to Acid Reducer Major?

A: Gastrointestinal disturbances like diarrhea and nausea are classified as common side effects in the safety profile. As the body adjusts to the drug, users may also experience related effects such as gas or bloating.

Q: Does Acid Reducer Major have an available generic version, and what is the difference?

A: Yes, the active ingredient in Acid Reducer Major, Cimetidine, is widely available as a generic medicine. Regulatory agencies like the FDA require that a generic version contains the same active ingredient and performs identically to the brand-name product.

Q: Do studies show that Acid Reducer Major is less effective for people who smoke?

A: Studies reviewed by regulatory bodies indicate that smoking can interfere with the effectiveness of this acid reducer. This effect has been particularly noted in clinical trials measuring the healing rates of ulcers in people who smoke compared to those who do not.

Q: Is it true that Acid Reducer Major is often used as part of a treatment plan for H. pylori infection?

A: According to official therapeutic indications, this medicine is often used as a component in a specific multi-drug treatment regimen. This regimen, which includes antibiotics, is used to treat infections caused by the bacterium Helicobacter pylori.

Q: Are there official statements about using Acid Reducer Major in conjunction with calcium supplements?

A: The mechanism by which this medicine reduces stomach acid can affect how other substances are absorbed by the body. Official patient information notes that this may include certain minerals and supplements, such as calcium.

Q: Has Acid Reducer Major been studied for safety and effectiveness in children under the age of 12?

A: Official labeling states that use in children as young as two years of age is permitted under specific defined protocols. However, it is also noted that the clinical data and overall experience for the pediatric population is less extensive than the data available for adults.

Q: Can Acid Reducer Major cause dark urine or other changes in kidney function markers?

A: The official safety profile for the drug lists rare, serious adverse reactions involving the hepatobiliary system, which refers to the liver and bile ducts. One such reaction is hepatitis, which may sometimes cause noticeable changes in urine color.

Q: Is the onset of action different depending on the specific condition being treated (e.g., heartburn vs. ulcers)?

A: The time it takes for the drug to start reducing acid production is consistent because the chemical mechanism is the same regardless of the condition being treated. Official drug profiles confirm that the physiological onset of action does not differ based on the specific upper GI condition (e.g., heartburn versus ulcers).

Q: Are there any clinical studies that have examined the long-term use of Acid Reducer Major in the elderly (over 70)?

A: Regulatory-reviewed studies have examined the long-term use of the drug for managing symptom recurrence. Official warnings note that older adults are conditional users of this drug and indicate that clinical monitoring is required due to the increased potential for certain side effects linked to age-related reduced kidney function.

How should Acid Reducer Major be stored and disposed of?

How to Store and Dispose of Acid Reducer Major (Cimetidine)

Official regulatory guidelines mandate specific conditions for storing and discarding this medicine to ensure stability and safety.


Storage Requirements

Acid Reducer Major tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be kept in its original container, which should be tightly closed, and protected from moisture. The medicine must always be stored out of the reach of children.

Disposal Instructions

Unused or expired medication should be disposed of by utilizing an authorized drug take-back program. If no program is available, the product should be disposed of by following specific governmental household disposal guidelines, which advise mixing the medicine with an unappealing substance, placing it in a sealed container, and discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acid Reducer Major found in:

A-Z Index: